Overall, a better understanding of the molecular mechanisms that determine how PrPC regulates NMDA receptor function will open up new therapeutic avenues in situations where the regulation of NMDA receptors by PrPC is perturbed, such as in AD and prion diseases. This evidence concerns the gene PRNP and prion disease.